(Approval lapsed) DOBUTamine injection, USP 250mg/20mL (12.5mg/mL) single-dose vials (Slate Run, USA)
Section 19A approved medicine
(Approval lapsed) DOBUTamine injection, USP 250mg/20mL (12.5mg/mL) single-dose vials (Slate Run, USA)
Section 19A approval holder
ORSPEC Pharma Pty Ltd ABN 15 634 980 417
Phone
(02) 4339 4239
Approved until
Status
Expired
Medicines in short supply/unavailable
DBL DOBUTAMINE 250mg/20mL (as hydrochloride) injection vial - ARTG 46451
Indication(s)
Indicated in adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.
Images
